SEQUANTRIX
Live / Registered — Registered (as of 01 Oct 2024)
What this means for you
Registered since 01 Oct 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79376918
- Registration number
- 7518440
- Mark type
- Stylized text
- Filed
- 20 Jul 2023
- Published for opposition
- 16 Jul 2024
- Registered
- 01 Oct 2024
- Attorney of record
- Nicholas D. Wells
Goods and services
- Class 005 — Pharmaceuticals: Biotechnological pharmaceutical preparations for medical use for the treatment of fibrosis; pharmaceutical preparations for the treatment of fibrosis; pharmaceutical preparations for treating fibrosis
- Class 042 — Scientific and technological services: Medical research; biomedical research and development services; biochemistry research and development services; biotechnological research and development services; pharmaceutical research and development services
Owner
- Sequantrix GmbH, DE
- Sequantrix GmbH, DE
- Sequantrix GmbH, DE
Prosecution history
- 13 Nov 2025 — NEW REPRESENTATIVE AT IB RECEIVED
- 29 Mar 2025 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 10 Mar 2025 — FINAL DISPOSITION NOTICE SENT TO IB
- 10 Mar 2025 — FINAL DISPOSITION PROCESSED
- 08 Feb 2025 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 22 Jan 2025 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 22 Jan 2025 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 01 Jan 2025 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 01 Oct 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 01 Oct 2024 — REGISTERED-PRINCIPAL REGISTER
- 16 Jul 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 16 Jul 2024 — PUBLISHED FOR OPPOSITION
- 16 Jul 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 16 Jul 2024 — PUBLISHED FOR OPPOSITION
- 26 Jun 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED